Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,938,098 papers from all fields of science
Search
Sign In
Create Free Account
TRANCE protein
Known as:
RANK Ligand
, RANKL Protein
, TNF Superfamily, Member 11
Expand
A transmembrane protein belonging to the tumor necrosis factor superfamily that specifically binds RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B and…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
In Blood
Process of secretion
TNFSF11 gene
TNFSF11 wt Allele
Expand
Narrower (1)
TNFSF11 protein, human
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
The development of denosumab for the treatment of diseases of bone loss and cancer‐induced bone destruction
C. Goessl
,
L. Katz
,
+5 authors
R. Wagman
Annals of the New York Academy of Sciences
2012
Corpus ID: 11485771
Denosumab is a fully human monoclonal antibody against RANK ligand (RANKL), an essential cytokine for the formation, function…
Expand
2012
2012
Cell Adhesion Signaling Regulates RANK Expression in Osteoclast Precursors
A. Mochizuki
,
M. Takami
,
+6 authors
R. Kamijo
PLoS ONE
2012
Corpus ID: 1866100
Cells with monocyte/macrophage lineage expressing receptor activator of NF-κB (RANK) differentiate into osteoclasts following…
Expand
2010
2010
Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin reduces bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasis
P. Holland
,
Robert E. Miller
,
+4 authors
W. Dougall
Cancer Biology & Therapy
2010
Corpus ID: 24838191
In bone metastases, tumor cells interact with the bone microenvironment to induce osteoclastogenesis, leading to bone destruction…
Expand
2005
2005
Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin.
F. von Knoch
,
A. Heckelei
,
+8 authors
M. von Knoch,
Journal of Biomedical Materials Research. Part A
2005
Corpus ID: 38767114
Alterations of the key regulators of osteoclastogenesis, receptor activator of NF-kappaB (RANK), RANK ligand (RANKL), and…
Expand
2004
2004
Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha.
M. Chaisson
,
D. Branstetter
,
+5 authors
W. Dougall
Journal of Biological Chemistry
2004
Corpus ID: 37864576
Signaling through the receptor activator of nuclear factor kappa B (RANK) is required for both osteoclast differentiation and…
Expand
2004
2004
Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506.
J. Fukunaga
,
T. Yamaai
,
+10 authors
Toshio Sugahara
Bone
2004
Corpus ID: 46238511
2004
2004
TNF receptor type 1 regulates RANK ligand expression by stromal cells and modulates osteoclastogenesis
Y. Abu-Amer
,
Sabiha Abbas
,
T. Hirayama
Journal of Cellular Biochemistry
2004
Corpus ID: 21763192
TNFα is a major osteoclastogenic cytokine and a primary mediator of inflammatory osteoclastogenesis. We have previously shown…
Expand
2002
2002
Histamine stimulates production of osteoclast differentiation factor/receptor activator of nuclear factor-kappaB ligand by osteoblasts.
Y. Deyama
,
T. Kikuiri
,
+5 authors
Kuniaki Suzuki
Biochemical and Biophysical Research…
2002
Corpus ID: 2949600
2002
2002
Immunolocalization of osteoclast differentiation factor in rat periodontium.
S. Kawamoto
,
S. Ejiri
,
K. Hoshi
,
E. Nagaoka
,
H. Ozawa
Archives of Oral Biology
2002
Corpus ID: 6646026
2000
2000
Low calcium environment effects osteoprotegerin ligand/osteoclast differentiation factor.
S. Takeyama
,
Yoshitaka Yoshimura
,
+6 authors
H. Fukuda
Biochemical and Biophysical Research…
2000
Corpus ID: 22964472
In coculture with osteoblastic cell line MC3T3-E1 (E1) and mouse bone marrow cells, we reported that numbers of osteoclasts rose…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE